KLRC4 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | O43908 |
|---|---|
| Clone Names | 100318079 |
| Gene ID | 8302 |
|---|---|
| Other Names | NKG2-F type II integral membrane protein, NK cell receptor F, NKG2-F-activating NK receptor, KLRC4, NKG2F |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | KLRC4 |
|---|---|
| Synonyms | NKG2F |
| Function | May play a role as a receptor for the recognition of MHC class I HLA-E molecules by NK cells. |
| Cellular Location | Membrane; Single-pass type II membrane protein. |
| Tissue Location | Natural killer cells. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Natural killer (NK) cells are lymphocytes that can mediatelysis of certain tumor cells and virus-infected cells withoutprevious activation. They can also regulate specific humoral andcell-mediated immunity. NK cells preferentially express severalcalcium-dependent (C-type) lectins, which have been implicated inthe regulation of NK cell function. KLRC4 is a member of the NKG2group which are expressed primarily in natural killer (NK) cellsand encodes a family of transmembrane proteins characterized by atype II membrane orientation (extracellular C terminus) and thepresence of a C-type lectin domain. The NKG2 gene family is locatedwithin the NK complex, a region that contains several C-type lectingenes preferentially expressed on NK cells. The 3' end of the KLRC4transcript includes the first non-coding exon found at the 5' endof the adjacent D12S2489E gene transcript.
References
Ucisik-Akkaya, E., et al. Mol. Hum. Reprod. 16(10):770-777(2010)Ma, J., et al. J. Med. Virol. 82(9):1501-1507(2010)Davila, S., et al. Genes Immun. 11(3):232-238(2010)Sellick, G.S., et al. Blood 111(3):1625-1633(2008)Cao, Q., et al. Zhonghua Nei Ke Za Zhi 45(10):824-826(2006)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.





Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.

